SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA 510(k) ...
SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted 510(k) clearance to a South Korea-based specialized medical AI startup for its non-contrast ...
A new trial has shown a sizeable and significant benefit of endovascular thrombectomy in acute ischemic stroke patients with a large vessel occlusion and an established large infarct identified with ...